Aclaris Therapeutics, Inc. (ACRS)

USD 1.13

(-0.44%)

Gross Profit Summary of Aclaris Therapeutics, Inc.

  • Aclaris Therapeutics, Inc.'s latest annual gross profit in 2023 was 13.16 Million USD , down -25.99% from previous year.
  • Aclaris Therapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was 857 Thousand USD , up 53.58% from previous quarter.
  • Aclaris Therapeutics, Inc. reported a annual gross profit of 17.79 Million USD in annual gross profit 2022, up 768.75% from previous year.
  • Aclaris Therapeutics, Inc. reported a annual gross profit of 2.04 Million USD in annual gross profit 2021, up 51.82% from previous year.
  • Aclaris Therapeutics, Inc. reported a quarterly gross profit of 857 Thousand USD for 2024 Q2, up 53.58% from previous quarter.
  • Aclaris Therapeutics, Inc. reported a quarterly gross profit of 11.14 Million USD for 2023 Q4, up 32.11% from previous quarter.

Annual Gross Profit Chart of Aclaris Therapeutics, Inc. (2023 - 2013)

Historical Annual Gross Profit of Aclaris Therapeutics, Inc. (2023 - 2013)

Year Gross Profit Gross Profit Growth
2023 13.16 Million USD -25.99%
2022 17.79 Million USD 768.75%
2021 2.04 Million USD 51.82%
2020 1.34 Million USD 684.3%
2019 172 Thousand USD -94.69%
2018 3.24 Million USD 580.88%
2017 476 Thousand USD 496.67%
2016 -120 Thousand USD -33.33%
2015 -90 Thousand USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%

Peer Gross Profit Comparison of Aclaris Therapeutics, Inc.

Name Gross Profit Gross Profit Difference
Applied DNA Sciences, Inc. 5.53 Million USD -137.972%
Aspira Women's Health Inc. 5.26 Million USD -150.247%
Biodesix, Inc. 36.07 Million USD 63.5%
BioNexus Gene Lab Corp. 1.32 Million USD -890.449%
bioAffinity Technologies, Inc. 791.61 Thousand USD -1563.435%
bioAffinity Technologies, Inc. 791.61 Thousand USD -1563.435%
Bionano Genomics, Inc. 9.56 Million USD -37.654%
CareDx, Inc 178.32 Million USD 92.616%
Check-Cap Ltd. -212 Thousand USD 6311.321%
Castle Biosciences, Inc. 174.8 Million USD 92.467%
DarioHealth Corp. 5.98 Million USD -120.053%
Exact Sciences Corporation 1.84 Billion USD 99.286%
Fulgent Genetics, Inc. 104.45 Million USD 87.394%
Guardant Health, Inc. 336.89 Million USD 96.091%
ICON Public Limited Company 1.81 Billion USD 99.274%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.399%
Illumina, Inc. 2.74 Billion USD 99.52%
Intelligent Bio Solutions Inc. 1.42 Million USD -823.664%
iSpecimen Inc. 5.1 Million USD -157.796%
Standard BioTools Inc. 50.45 Million USD 73.899%
MDxHealth SA 43.92 Million USD 70.024%
23andMe Holding Co. 99.37 Million USD 86.749%
Medpace Holdings, Inc. 524.5 Million USD 97.489%
Myriad Genetics, Inc. 476.4 Million USD 97.236%
Mainz Biomed B.V. 509.65 Thousand USD -2483.688%
ENDRA Life Sciences Inc. -275.45 Thousand USD 4880.524%
NeoGenomics, Inc. 244.6 Million USD 94.617%
Neogen Corporation 463.9 Million USD 97.161%
Inotiv, Inc. 165.44 Million USD 92.041%
Natera, Inc. 492.74 Million USD 97.328%
OpGen, Inc. -90.69 Thousand USD 14619.152%
OPKO Health, Inc. 318.12 Million USD 95.861%
Psychemedics Corporation 8.41 Million USD -56.52%
Prenetics Global Limited 8.82 Million USD -49.13%
Prenetics Global Limited 8.82 Million USD -49.13%
Precipio, Inc. 6.01 Million USD -118.81%
Personalis, Inc. 18.2 Million USD 27.68%
RadNet, Inc. 93 Million USD 85.841%
Sera Prognostics, Inc. 96 Thousand USD -13616.667%
Sotera Health Company 577.15 Million USD 97.718%
Neuronetics, Inc. 51.7 Million USD 74.532%
Star Equity Holdings, Inc. 11.92 Million USD -10.414%
Star Equity Holdings, Inc. 11.92 Million USD -10.414%
Trinity Biotech plc 19.45 Million USD 32.298%
T2 Biosystems, Inc. -8.17 Million USD 261.175%
Twist Bioscience Corporation 133.34 Million USD 90.125%
Exagen Inc. 29.45 Million USD 55.296%